SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001590750-19-000042
Filing Date
2019-08-08
Accepted
2019-08-07 18:59:12
Documents
66
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mgen-q22019x10q.htm 10-Q 1172891
2 EXHIBIT 31.1 mgen-q22019xex311.htm EX-31.1 12678
3 EXHIBIT 31.2 mgen-q22019xex312.htm EX-31.2 12786
4 EXHIBIT 32.1 mgen-q22019xex321.htm EX-32.1 15145
  Complete submission text file 0001590750-19-000042.txt   5164385

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mgen-20190630.xml EX-101.INS 857010
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgen-20190630.xsd EX-101.SCH 43026
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mgen-20190630_cal.xml EX-101.CAL 59482
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mgen-20190630_def.xml EX-101.DEF 223489
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgen-20190630_lab.xml EX-101.LAB 541559
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgen-20190630_pre.xml EX-101.PRE 321234
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 303-531-5952
MIRAGEN THERAPEUTICS, INC. (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36483 | Film No.: 191007022
SIC: 8071 Services-Medical Laboratories